Display options
Cite
Soni P, Khandelwal K, Aara N, et al. Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual Warts. J Cutan Aesthet Surg. 2011;4(3):188-91doi: 10.4103/0974-2077.91250.
Soni, P., Khandelwal, K., Aara, N., Ghiya, B. C., Mehta, R. D., & Bumb, R. A. (2011). Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual Warts. Journal of cutaneous and aesthetic surgery, 4(3), 188-91. https://doi.org/10.4103/0974-2077.91250
Soni, Prasoon, et al. "Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual Warts." Journal of cutaneous and aesthetic surgery vol. 4,3 (2011): 188-91. doi: https://doi.org/10.4103/0974-2077.91250
Soni P, Khandelwal K, Aara N, Ghiya BC, Mehta RD, Bumb RA. Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual Warts. J Cutan Aesthet Surg. 2011 Sep;4(3):188-91. doi: 10.4103/0974-2077.91250. PMID: 22279384; PMCID: PMC3263129.
Copy Download .nbib Format: NLM
Share it on

J Cutan Aesthet Surg. 2011 Sep;4(3):188-91. doi: 10.4103/0974-2077.91250.

Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual Warts.

Journal of cutaneous and aesthetic surgery

Prasoon Soni, Kanika Khandelwal, Naushin Aara, Bhikam C Ghiya, Rajesh D Mehta, Ram A Bumb

Affiliations

  1. Departments of Dermatology, Venereology and Leprosy, SP Medical College, Bikaner, Rajasthan, India.

PMID: 22279384 PMCID: PMC3263129 DOI: 10.4103/0974-2077.91250

Abstract

BACKGROUND/AIM: Intralesional bleomycin gained increasing popularity in the recent past for treatment of warts particularly in palmo-plantar and periungual regions as other modalities are not very effective. Hence we evaluated the role of intralesional bleomycin in periungual and palmo-plantar warts to know its efficacy in Indian patients.

SETTINGS AND DESIGN: This was a placebo-controlled study.

MATERIALS AND METHODS: Fifty patients of multiple palmo-plantar and periungual warts were included in this study and categorized in groups A and B of 25 each. Alternate patients were included in groups A and B and treated respectively with intralesional bleomycin (1 mg/mL solution) and normal saline as placebo, fortnightly for maximum up to two injections. Patients were followed up weekly for 1 month, fortnightly up to 12 weeks, and then quarterly for 1 year. If warts persisted after 12 weeks of starting treatment, it was considered a failure. Statistical analysis was done by the chi-square test using M-stat software.

RESULTS: Group A and B patients were having 85 warts and 72 warts, respectively. The cure rate in group A and B patients was 96.47% (82/85 warts) and 11.11% (8/72 warts), respectively, after one or two injections within 12 weeks. The difference in the cure rate between two groups was statistically highly significant (<0.0001). In group A patients, a haemorrhagic eschar was formed which gradually healed in 8-12 weeks without atrophy or pigmentation; this phenomenon was not seen in group B. Only moderate pain was observed by most of the patients during injection in both groups.

CONCLUSION: The intralesional injection of bleomycin is highly effective, safe, and non-toxic in periungual and palmo-plantar warts.

Keywords: Bleomycin; intralesional injection; palmo-plantar and periungual warts

References

  1. Br J Dermatol. 1994 Dec;131(6):883-6 - PubMed
  2. Br J Dermatol. 1989 Jul;121(1):99-105 - PubMed
  3. J Am Podiatr Med Assoc. 2006 May-Jun;96(3):220-5 - PubMed
  4. J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):1002-6 - PubMed
  5. Dermatol Surg. 1999 May;25(5):377-80 - PubMed
  6. Br J Dermatol. 1984 Aug;111(2):197-207 - PubMed
  7. Cutis. 1980 Sep;26(3):319-20, 322, 324 - PubMed
  8. Arch Dermatol. 1991 Feb;127(2):234-6 - PubMed
  9. Cutis. 1976 Aug;18(2):264-6 - PubMed
  10. Australas J Dermatol. 2003 Aug;44(3):169-73 - PubMed
  11. Pediatr Dermatol. 2001 May-Jun;18(3):249-51 - PubMed
  12. Clin Med Res. 2006 Dec;4(4):273-93 - PubMed
  13. J Dermatolog Treat. 2006;17(2):112-6 - PubMed
  14. J Am Acad Dermatol. 1983 Jul;9(1):91-6 - PubMed
  15. Br J Dermatol. 2001 Jan;144(1):4-11 - PubMed
  16. Cancer Treat Rep. 1982 Feb;66(2):359-62 - PubMed
  17. J Drugs Dermatol. 2006 Jun;5(6):499-504 - PubMed
  18. Arch Dermatol. 1973 Jul;108(1):79-82 - PubMed

Publication Types